Table of Contents
Molecular Biology International
Volume 2016, Article ID 4328697, 9 pages
Review Article

Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis

1Department of Molecular and Human Genetics, Banaras Hindu University, Varanasi 221 005, India
2Department of Zoology, Mahila Mahavidyalaya, Banaras Hindu University, Varanasi 221 005, India

Received 29 July 2016; Revised 7 October 2016; Accepted 17 October 2016

Academic Editor: Sharad S. Singhal

Copyright © 2016 Deepshikha Mishra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The human CD10 antigen is a single pass, type II transmembrane, 100 kD cell surface glycoprotein belonging to peptidase M13 family. Identified in common acute lymphoblastic leukemia as a cancer specific antigen, CD10 is a cell surface ectoenzyme widely expressed on different types of cells. Earlier, it was used only as a cell surface marker to identify and differentiate between haematological malignancies. Later, reported to be present in various malignancies, it is thought to play significant role in cancer development and progression. Regulated expression of CD10 is necessary for angiogenesis and so forth. However its expression level is found to be deregulated in different cancers. In some cancers, it acts as tumor suppressor and inhibits tumor progression whereas in others it has tumor promoting tendency. However, its role in tumorigenesis remains unclear. This review summarises structural features, functions, and probable role of CD10 in cancer development.